EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Polymorphisms in SCN1A Gene (rs6432860) and Pharmacoresistance to Antiepileptic Drugs Among Jordanian Patients with Epilepsy

Hanen Al-Sadir, Ayat Al-Farhood, Al-Motassem Yousef iD, Rami Abduljabbar iD, Shayma Abdullah iD, Ali Abuhaliema iD, Violet Kasabri iD

Pharmaceuticals · 30.04.2026 · 19 (5) · 712

DOI: 10.3390/ph19050712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 30.04.2026. Verfasst von Hanen Al-Sadir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman 11942, Jordan. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We investigated whether common variants in SCN1A are associated with antiepileptic drug (AED) non-response in Jordanian patients with epilepsy.

Methods

We recruited 114 patients (105 successfully genotyped) and Sanger-sequenced five loci spanning rs6432860 and its flanking region of rs1531380, rs1531379, rs1531378, and rs10198801. Genotype–response associations were tested using contingency analyses and multivariable logistic regression adjusting for age at the time of the interview, number of AEDs, and carbamazepine use. Pre-specified secondary analyses included (i) stratification by AED class (voltage-gated sodium channel [VGSC]-acting vs. non-VGSC agents) and (ii) sensitivity analyses using alternative non-response thresholds (seizures > 0/year and ≥4/year). Linkage disequilibrium (LD) and exact Hardy–Weinberg equilibrium (HWE) tests were evaluated. Cohort minor allele frequencies (MAFs) were compared with global population estimates.

Results

The four upstream previously cataloged intronic variant SNPs (rs1531380, rs1531379, rs1531378, and rs6432860) were in a complete pattern of LD association in this population (D′ = 1; r2 = 1) whereas each upstream variant with rs10198801 showed D′ = 1 with inverse correlation (r ≈ −0.53). All loci conformed to the exact HWE tests. Upstream variants had novel associations with a non-response in unadjusted analyses and remained significant after adjustment (genotype aOR = 2.8; 95% CI = 1.1–7.2; p value = 0.03), alongside independent effects of carbamazepine use (aOR = 3.3; 95% CI = 1.3–8.0; p value = 0.009) and a number of AEDs (aOR = 0.17; 95% CI = 0.06–0.50; p value = 0.002). In AED-class stratification, upstream additional intronic variants had novel associations with a non-response among VGSC-treated patients (OR = 3.8; 95% CI = 1.1–13.6; p value = 0.03) whereas rs10198801 was associated among non-VGSC patients (OR = 7.9; 95% CI = 0.9–70; p value = 0.04). Findings were robust using a ≥4 seizures/year threshold (recessive model significant) but not using any seizures > 0/year. Cohort MAFs for upstream variants (~48.6%) exceeded European, African, and Asian estimates. Significance: SCN1A upstream intronic variation has a novel association with AED non-response in the Jordanian cohort, shows mechanism-aligned patterns by AED class, persists after covariate adjustment and under a clinically used seizure-frequency threshold, and warrants ancestry-informed replication and functional validation.

Schlagwörter

Stichwörter der Autor:innen

SCN1Aantiepileptic drugsdrug resistanceepilepsyseizuresingle-nucleotide polymorphisms

Autor:innen und Institutionen

  • Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman 11942, Jordan.
  • Clinical Pharmacy and Therapeutics in Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19111, Jordan.

ORCID-Profile: Al-Motassem Yousef, Rami Abduljabbar, Shayma Abdullah, Ali Abuhaliema, Violet Kasabri

Förderung

  • University of Jordan

Zitieren

APA

Al-Sadir, H., Al-Farhood, A., Yousef, A. M., Abduljabbar, R., Abdullah, S., Abuhaliema, A., & Kasabri, V. (2026). Genetic Polymorphisms in SCN1A Gene (rs6432860) and Pharmacoresistance to Antiepileptic Drugs Among Jordanian Patients with Epilepsy. Pharmaceuticals, 19(5), 712. https://doi.org/10.3390/ph19050712

Vancouver

Al-Sadir H, Al-Farhood A, Yousef AM, Abduljabbar R, Abdullah S, Abuhaliema A, et al. Genetic Polymorphisms in SCN1A Gene (rs6432860) and Pharmacoresistance to Antiepileptic Drugs Among Jordanian Patients with Epilepsy. Pharmaceuticals. 2026;19(5):712. doi:10.3390/ph19050712

BibTeX
@article{AlSadir2026,
  author = {Al-Sadir, Hanen and Al-Farhood, Ayat and Yousef, Al-Motassem and Abduljabbar, Rami and Abdullah, Shayma and Abuhaliema, Ali and Kasabri, Violet},
  title = {Genetic Polymorphisms in SCN1A Gene (rs6432860) and Pharmacoresistance to Antiepileptic Drugs Among Jordanian Patients with Epilepsy},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {712},
  doi = {10.3390/ph19050712}
}
Kostenlos starten →